Combination therapy with normobaric oxygen (NBO) plus thrombolysis in experimental ischemic stroke

Combination therapy with normobaric oxygen (NBO) plus thrombolysis in experimental ischemic stroke

<p>Abstract</p> <p>Background</p> <p>The widespread use of tissue plasminogen activator (tPA), the only FDA-approved acute stroke treatment, remains limited by its narrow therapeutic time window and related risks of brain hemorrhage. Normobaric oxygen therapy (NBO) may...

Full description

Bibliographic Details
Main Authors: Singhal Aneesh B, Wu Ona, Lu Jie, Egi Yasuhiro, Arai Ken, Murata Yoshihiro, Fujiwara Norio, Lo Eng H
Format: Article
Language:English
Published: BMC 2009-07-01
Series:BMC Neuroscience
Online Access:http://www.biomedcentral.com/1471-2202/10/79

Similar Items

Similar Items